ARTICLE | Clinical News
Atrix completes enrollment
May 31, 2000 7:00 AM UTC
ATRX completed enrollment of 120 patients in a U.S. Phase III trial of its Atrigel subcutaneous 30-day sustained release formulation of leuprolide gonadotropin-releasing hormone (GnRH) agonist to trea...